This list presents the 20 highest-revenue companies among the 34 listed companies in the biotech drug discovery sector, together with their stock names and key metrics. Figures including ticker codes, market valuations and revenue are organized in a table.
There are 34 listed companies in biotech drug discovery. The article covers the 20 highest-revenue companies among them and presents metrics including ticker code, stock name, PER, PBR, market capitalization, revenue, operating profit, EV/EBITDA, ROE, ROA and net cash in a table.
The table also lists each company's major, intermediate and minor category classifications, identifying them as biotech drug discovery companies within the medical, pharmaceutical and biotech sectors. Some items may be shown as "-" for stocks for which data is unavailable.
Kyowa Kirin ranks first, with market capitalization of ¥1,377,425 million, revenue of ¥496,826 million, ROE of 7.7%, ROA of 6.1% and net cash of ¥241,114 million. JCR Pharmaceuticals and Nxera Pharma also rank among the leaders, with metrics for revenue, profit and capital efficiency shown alongside them.
The table is provided with supplementary links to stock price charts and earnings information and is available to view free of charge.